Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hioe

Showing results (131-140 of 157) with videos related to

Pageof 16
Sort By:
Plos Pathogens|December 28, 2020
Signal peptide of HIV-1 envelope modulates glycosylation impacting exposure of V1V2 and other epitopesChitra Upadhyay, Roya Feyznezhad, Liwei Cao, et al.
Journal of Virology|June 26, 2015
Functional and Structural Characterization of Human V3-Specific Monoclonal Antibody 2424 with Neutralizing Activity against HIV-1 JRFLRajnish Kumar, Ruimin Pan, Chitra Upadhyay, et al.
The Journal of Infectious Diseases|August 30, 2020
A High-Throughput Assay for Circulating Antibodies Directed Against the S Protein of Severe Acute Respiratory Syndrome Coronavirus 2Svenja Weiss, Jéromine Klingler, Catarina Hioe, et al.
Frontiers in Immunology|November 13, 2018
Modulation of Antibody Responses to the V1V2 and V3 Regions of HIV-1 Envelope by Immune Complex VaccinesCatarina E Hioe, Rajnish Kumar, Chitra Upadhyay, et al.
Vaccine|November 1, 1996
Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activityD F Nixon, C Hioe, P D Chen, et al.
Vaccine|April 1, 1996
Comparison of adjuvant formulations for cytotoxic T cell induction using synthetic peptidesC E Hioe, H Qiu, P D Chend, et al.
Frontiers in Immunology|May 23, 2024
Heterologous Ad26/Ad5 adenovirus-vectored vaccines elicited SARS-CoV-2-specific antibody responses with potent Fc activitiesJéromine Klingler, Shreyas Kowdle, Juan C Bandres, et al.
Iscience|November 21, 2022
Immune profiles to distinguish hospitalized versus ambulatory COVID-19 cases in older patientsJéromine Klingler, Gregory S Lambert, Juan C Bandres, et al.
Frontiers in Immunology|October 9, 2024
Signal peptide exchange alters HIV-1 envelope antigenicity and immunogenicityChitra Upadhyay, Priyanka Rao, Mohammad Amin Behzadi, et al.
Journal of Virology|July 18, 2008
Human immunodeficiency virus type 1 envelope gp120 induces a stop signal and virological synapse formation in noninfected CD4+ T cellsGaia Vasiliver-Shamis, Michael Tuen, Teresa W Wu, et al.
Pageof 16

Showing results (131-140 of 157) with videos related to

Sort By:
Pageof 16
Plos Pathogens|December 28, 2020
Signal peptide of HIV-1 envelope modulates glycosylation impacting exposure of V1V2 and other epitopesChitra Upadhyay, Roya Feyznezhad, Liwei Cao, et al.
Journal of Virology|June 26, 2015
Functional and Structural Characterization of Human V3-Specific Monoclonal Antibody 2424 with Neutralizing Activity against HIV-1 JRFLRajnish Kumar, Ruimin Pan, Chitra Upadhyay, et al.
The Journal of Infectious Diseases|August 30, 2020
A High-Throughput Assay for Circulating Antibodies Directed Against the S Protein of Severe Acute Respiratory Syndrome Coronavirus 2Svenja Weiss, Jéromine Klingler, Catarina Hioe, et al.
Frontiers in Immunology|November 13, 2018
Modulation of Antibody Responses to the V1V2 and V3 Regions of HIV-1 Envelope by Immune Complex VaccinesCatarina E Hioe, Rajnish Kumar, Chitra Upadhyay, et al.
Vaccine|November 1, 1996
Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activityD F Nixon, C Hioe, P D Chen, et al.
Vaccine|April 1, 1996
Comparison of adjuvant formulations for cytotoxic T cell induction using synthetic peptidesC E Hioe, H Qiu, P D Chend, et al.
Frontiers in Immunology|May 23, 2024
Heterologous Ad26/Ad5 adenovirus-vectored vaccines elicited SARS-CoV-2-specific antibody responses with potent Fc activitiesJéromine Klingler, Shreyas Kowdle, Juan C Bandres, et al.
Iscience|November 21, 2022
Immune profiles to distinguish hospitalized versus ambulatory COVID-19 cases in older patientsJéromine Klingler, Gregory S Lambert, Juan C Bandres, et al.
Frontiers in Immunology|October 9, 2024
Signal peptide exchange alters HIV-1 envelope antigenicity and immunogenicityChitra Upadhyay, Priyanka Rao, Mohammad Amin Behzadi, et al.
Journal of Virology|July 18, 2008
Human immunodeficiency virus type 1 envelope gp120 induces a stop signal and virological synapse formation in noninfected CD4+ T cellsGaia Vasiliver-Shamis, Michael Tuen, Teresa W Wu, et al.
Pageof 16